Scholarlink

<p>Sprouting angiogenesis requires endothelial cells (ECs) to transition into specialized tip and stalk cells, a process influenced by metabolic regulation. ATP-citrate lyase (ACLY), which generates acetyl-CoA from citrate, is markedly activated in proliferating ECs (PECs) but less so in quiescent ECs (QECs). However, it remains elusive whether ACLY-derived acetyl-CoA fuels angiogenesis. Here, we demonstrate the critical role of ACLY in angiogenesis. ACLY depletion impaired EC proliferation, migration, tube formation, and sprouting, while EC-specific <i>Acly</i>-knockout mice showed reduced physiological and pathological angiogenesis, including in oxygen-induced retinopathy (OIR). Mechanistically, ACLY fuels glycolysis, boosts acetyl-CoA production, and enhances histone acetylation at key angiogenic gene loci. Intriguingly, acetate supplementation restored acetyl-CoA levels and rescued defective angiogenesis in ACLY-deficient models. In addition, pharmacological inhibition of ACLY suppressed neovascularization in OIR models. These findings establish ACLY as a previously unrecognized metabolic and epigenetic regulator of angiogenesis, highlighting its potential as a therapeutic target for pathological neovascularization.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ATP-citrate lyase is a critical regulator of physiological and pathological angiogenesis

  • 期刊论文

  • 发表日期：

    2026年3月4日

查看全文
  • Chong Xu,
  • Ying Lin,
  • Zeyu Wang,
  • Cailin Feng,
  • Lingfeng Luo,
  • Shuai Guo,
  • Han Zhang,
  • Lu Liu,
  • Azhen Fan,
  • Penglong Qi,
  • Dongyang Jiang,
  • Yiming Xu,
  • Yawei Xu,
  • Weiming Li,
  • Wenliang Che,
  • Suowen Xu,
  • Guofu Zhu

摘要

Sprouting angiogenesis requires endothelial cells (ECs) to transition into specialized tip and stalk cells, a process influenced by metabolic regulation. ATP-citrate lyase (ACLY), which generates acetyl-CoA from citrate, is markedly activated in proliferating ECs (PECs) but less so in quiescent ECs (QECs). However, it remains elusive whether ACLY-derived acetyl-CoA fuels angiogenesis. Here, we demonstrate the critical role of ACLY in angiogenesis. ACLY depletion impaired EC proliferation, migration, tube formation, and sprouting, while EC-specific Acly-knockout mice showed reduced physiological and pathological angiogenesis, including in oxygen-induced retinopathy (OIR). Mechanistically, ACLY fuels glycolysis, boosts acetyl-CoA production, and enhances histone acetylation at key angiogenic gene loci. Intriguingly, acetate supplementation restored acetyl-CoA levels and rescued defective angiogenesis in ACLY-deficient models. In addition, pharmacological inhibition of ACLY suppressed neovascularization in OIR models. These findings establish ACLY as a previously unrecognized metabolic and epigenetic regulator of angiogenesis, highlighting its potential as a therapeutic target for pathological neovascularization.